Total dietary fat and fatty acid content modifies plasma phospholipid fatty acids, desaturase activity indices, and urinary prostaglandin E in women

Nutrition Research

Volumn 32, Issue 1, 2012, Pages 1-7

  Raatz, Susan K ^a,b   Young, Lindsay R ^b   Picklo, Matthew J ^a,c   Sauter, Edward R ^c   Qin, Wenyi ^c   Kurzer, Mindy S ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Delta 5 desaturase; Delta 6 desaturase; Dietary fat; Omega 3 fatty acids; Phospholipid fatty acids; Prostaglandin E 2; Women

Indexed keywords

ACYL COENZYME A DESATURASE; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; PHOSPHOLIPID; PROSTAGLANDIN E2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENZYME ACTIVITY; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; NUTRITIONAL ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN MODIFICATION; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; WOMEN'S HEALTH;

AGED; ALPHA-LINOLENIC ACID; ARACHIDONIC ACID; CROSS-OVER STUDIES; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; EICOSAPENTAENOIC ACID; FATTY ACID DESATURASES; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LINOLEIC ACID; LINOLEOYL-COA DESATURASE; MIDDLE AGED; PHOSPHOLIPIDS; POSTMENOPAUSE; PROSTAGLANDINS E; RISK FACTORS;

EID: 84855931780     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.12.006     Document Type: Article

References (43)

1. Anderson A.L., Harris T.B., Tylavsky F.A., Perry S.A., Houston D.K., Hue T.F., Health ABC Study, et al. Dietary patterns and survival in older adults. J Am Diet Assoc 2001, 111:84-91.
2. Osler M., Heitmann B.L., Gerdes L.U., Jorgensen L.M., Schroll M. Dietary patterns and mortality in Danish men and women: a prospective observational study. Br J Nutr 2001, 85:219-225.
3. Knoops K.T., de Groot L.C., Fidanza F., Albertini-Fidanza A., Kromhout D., van Staveren W.A. Comparison of three different dietary scores in relation to 10-year mortality in elderly Europeans subjects: the HALE project. Eur J Clin Nutr 2006, 60:746-755.
4. Bray G.A., Popkin B.M. Dietary fat intake does affect obesity. Am J Clin Nutr 1998, 68:1157-1173.
5. Aro A., Pietinen P., Valsta L.M., Turpeinen A.M., Ehnholm C., Dougherty R.M., et al. Effects of reduced-fat diets with different fatty acid compositions on serum lipoprotein lipids and apolipoproteins. Pub Health Nutr 1998, 1:109-116.
6. Hibbeln J.R., Nieminen L.R.G., Blasbalg T.L., Riggs J.A., Lands W.E.M. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 2006, 83:1483S-1493S.
7. th century. Am J Clin Nutr 2011, 93:95-962.
8. Cordain L., Eaton S.B., Sebsastiain A., Mann N., Lindeberg S., Watkins B.A., et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 2005, 81:341-354.
9. Raatz S.K., Bibus D., Thomas W., Kris Etherton P. Total fat intake modifies plasma fatty acid composition. J Nutr 2001, 231-234.
10. Harris W.S., Mozaffarian D., Lefevre M., Toner C.D., Colombo J., Cunnane S.C., et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009, 139:804S-819S.
11. Jung U.J., Torrejon C., Tighe A.P., Deckelbaum R.J. n-3 fatty acids and cardiovascular disease: Mechanisms underlying beneficial effects. Am J Clin Nutr 2008, 87:2003S-2009S.
12. James M.J., Proudman S.M., Cleland L.G. Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis. Prostaglandins Leukot Essent Fatty Acids 2003, 68:399-405.
13. Leon H., Shibata M.C., Sivakumaran S., Dorgan M., Chatterley T., Tsuyuki R.T. Effect of fish oil on arrhythmias and mortality: systematic review. Br Med J 2008, 337:2931.
14. Calder P.C. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002, 61:345-358.
15. Serhan C.N., Gotlinger K., Hong S., Lu Y., Siegelman J., Baer T., et al. Anti-inflammatory actions of neuroprotectinD1/Protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 2006, 176:1848-1859.
16. Song W.L., Paschos G., Fries S., Reilly M.P., Yu Y., Rokach J., et al. Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation. J Biol Chem 2009, 284:23636-23643.
17. Gao L., Wang J., Sekhar K.R., Yin H., Yared N.F., Schneider S.N., et al. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem 2007, 282:2529-2537.
18. Tjonahen E., Oh S.F., Siegelman J., Elangovan S., Percarpio K.B., Hong S., et al. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem Biol 2006, 13:1193-1202.
19. Goodwin J.S., Bankhurst A.D., Messner R.P. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med 1977, 146:1719-1734.
20. Wasserman J., Hammarstrom S., Petrini B., Blomgren H., von Stedingk L., Vedin I. Effects of some prostaglandins and leukotrienes on lymphocytes, monocytes and their activity in vitro. Int Arch Allergy Appl Immunol 1987, 83:39-43.
21. Calder P.C. Polyunsaturated fatty acids and inflammation. Biochem Soc Transact 2005, 33:423-427.
22. Whelan J. Antagonistic effects of dietary arachidonic acid and n-3 polyunsaturated fatty acids. J Nutr 1996, 1086S-1091S.
23. Nakamura M.T., Nara T.Y. Structure, function and dietary regulation of δ6, δ5, and δ9 desaturases. Ann Rev Nutr 2004, 24:345-376.
24. Young L.R., Kurzer M.S., Thomas W., Redmon J.B., Raatz S.K. Effect of dietary fat and omega-3 fatty acids on urinary eicosanoids and sex hormone concentrations in postmenopausal women: a randomized controlled feeding trial. Nutr Cancer 2011, 63:930-939.
25. Raz A., Kamin-Belsky N., Przedecki F., Obukowicz M.G. Fish oil inhibits δ6 desaturase activity in vivo: utility in a dietary paradigm to obtain mice depleted of arachidonic acid. J Nutr Biochem 1997, 8:558-565.
26. National Institutes of Health, Diet History Questionnaire Internet:. http://www.riskfactor.cancer.gov/DHQ/forms/files/shared/dhq1.2002.sample.pdf.
27. Vessby B., Gustafsson I.B., Tengblad S., Boberg M., Andersson A. Desaturation and elongation of fatty acids and insulin action. Ann NY Acad Sci 2002, 967:183-195.
28. Warensjo E., Rosell M., Hellenius M.L., Vessby B., De Faire U., Riserus U. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance. Lipids Health Dis 2009, 8:37.
29. Calder P.C., Dangour A.D., Diekman C., Eilander A., Koletzko B., Meijer G.W., et al. Essential fats for future health. Proceedings of the 9th Unilever Nutrition Symposium, 26-27 May 2010. Eur J Clin Nutr 2010, 64:S1-13.
30. USDA, ARS. 2010. Nutrient intake from food: mean amounts consumed her individual, by gender and age, what we eat in America, NHANES 2007-2008 http://www.ars.usda.gov/ba/bhnrc/fsrg.
31. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296:1885-1899.
32. Kawashima A., Sugawara S., Okita M., Akahane T., Fukui K., Hashiuchi M., et al. Plasma fatty acid composition, estimated desaturase activities, and intakes of energy and nutrients in Japanese men with abdominal obesity or metabolic syndrome. J Nutr Sci Vitaminol 2009, 55:400-409.
33. Dang A.Q., Kemp K., Faas F.H., Carter Effects of dietary fats on fatty acid composition and δ5 desaturase in normal and diabetic rats. Lipids 1989, 10:882-889.
34. Cho H.P., Nakamura M., Clark S.D. Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J Biol Chem 1999, 274:37335-37339.
35. Cho H.P., Nakamura M., Clark S.D. Cloning, expression, and fatty acid regulation of the mammalian delta-6 desaturase. J Biol Chem 1999, 274:471-477.
36. Martinelli N., Consoli L., Oliveri O. A "desaturase hypothesis" for atherosclerosis: Janus-faced enzymes in w-6 and w-3 polyunsaturated fatty acid metabolism. J Nutrigenet Nutrigenom 2009, 2:129-139.
37. Riccardi G., Giacco R., Riveellesse A.A. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004, 23:447-456.
38. King I.B., Lemaitre R.N., Kestin M. Effect of a low-fat diet on fatty acid composition in red cells, plasma phospholipids, and cholesterol esters: investigation of a biomarker of total fat intake. Am J Clin Nutr 2006, 83:227-236.
39. Warensjo E., Riserus U., Vessby B. Fatty acid composition of serum lipids predicts the development of metabolic syndrome. Diabetologia 2005, 48:1999-2005.
40. Warensjo E., Ohrvall M., Vessby B. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in man and women. Nutr Metab Cardiovasc Dis 2006, 16:128-136.
41. Kelley D.S. Modulation of human immune and inflammatory responses by dietary fatty acids. Nutr 2001, 17:669-673.
42. Massaro M., Habib A., Lubrano L., Del Turco S., Lazzerini G., Bourcier T., et al. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP((H) oxidase and PKCE inhibition. PNAS 2006, 103:15184-15189.
43. Trebble T.M., Wootton S.A., Miles E.A., Mullee M., Arden N.K., Ballinger A.B., et al. Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant co-supplementation. Am J Clin Nutr 2003, 78:376-382.